Form 4: Guardant Health Executive Kumud Kalia Reports Stock Transactions
SEC Form 4 Filing
Guardant Health's Chief Information Officer, Kumud Kalia, reported the acquisition of 710 shares of common stock and the disposal of 360 shares to cover tax obligations related to vesting restricted stock units.
Summary
- Kumud Kalia, Chief Information Officer at Guardant Health, reported transactions involving the company's stock on December 1, 2024.
- Kalia acquired 710 shares of common stock through the vesting of restricted stock units.
- Additionally, 360 shares were disposed of to cover tax withholding obligations associated with the vesting of these units.
- Following these transactions, Kalia directly owns 18,094 shares of Guardant Health common stock.
- Kalia also holds 2,131 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a routine SEC filing detailing stock transactions by an executive, which is neither positive nor negative in itself. It is a neutral event.
Industry Context
This is a routine filing related to executive compensation and stock ownership, which is common in publicly traded companies. It provides transparency into the transactions of company insiders.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider transactions.
- The vesting schedule of the restricted stock units, with 25% vesting initially and the remainder quarterly over three years, is a common structure for equity compensation.
- The tax withholding process, where shares are sold to cover tax obligations, is also a standard practice.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect routine executive compensation activities.
- The filing provides transparency to the market regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 12/01/2024 | Date of stock transactions including acquisition of shares and disposal for tax obligations. |
| 12/02/2024 | Date the Form 4 was signed. |
Keywords
Guardant Health, stock transaction, Form 4, insider trading, restricted stock units, executive compensation, Kumud Kalia
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.